Objectives: We sought to elucidate the gene expression profiles of the causative genes as well as the localization of the encoded proteins involved in hereditary hearing loss. Methods: Relevant articles (as of September 2014) were searched in PubMed databases, and the gene symbols of the genes reported to be associated with deafness were located on the Hereditary Hearing Loss Homepage using localization, expression, and distribution as keywords. Results: Our review of the literature allowed us to systematize the gene expression profiles for genetic deafness in the inner ear, clarifying the unique functions and specific expression patterns of these genes in the cochlea and vestibular endorgans. Conclusions: The coordinated actions of various encoded molecules are essential for the normal development and maintenance of auditory and vestibular function.
Introduction
Hearing loss is one of the most common and frequently diagnosed sensory disorders worldwide, with 50% to 70% of cases attributable to genetic causes. 1 Hereditary hearing loss demonstrates great heterogeneity. To date, over 80 genes have been identified as causing nonsyndromic hearing loss, and approximately 100 genes are presumed to be involved in hearing loss. 2 The coordinated actions of various encoded molecules are essential for the normal development and maintenance of auditory processing in the cochlea. The identification of deafness-associated genes has been the most influential factor in the recent extensive advances in our knowledge of the biology of hearing.
In terms of clinical applications, the most remarkable aspect of these advances is that ENT clinicians can now make highly accurate molecular diagnoses through the use of genetic testing, enabling a clearer understanding of the mechanisms involved, more appropriate and precise treatment selection, and greatly improved genetic counseling.
Recent advances in genetic analysis technology using massively parallel DNA sequencing have not only accelerated the exploration of novel genes involved in genetic hearing loss but have also allowed the identification of mutations in rare causative genes.
However, such rapid progress in gene/mutation identification has, at times, disrupted our understanding of their precise function. It is now necessary to systematize the huge amounts of data available on the expression and localization profiles of causative genes.
The present review highlights the gene expression profiles of the causative genes as well as the localization of the encoded proteins involved in hereditary hearing loss. We conducted a literature search for studies describing in situ hybridization, reporter expression, and immunocytochemistry. In addition, we also reported functional predictions using
Results and Discussions
A review of the gene expression profiles for hearing lossassociated genes in the inner ear revealed their unique functions and specific expression patterns of the genes in the cochlear and vestibular endorgans (Figures 1, 2, and 3 ). Each cell-specific gene expression profile is discussed in the following.
Inner Hair Cells Are Crucial for Sound Transduction
Inner hair cells (IHCs), the actual sensory receptors, play a crucial role in the conversion of mechanical movements to electric signals. [8] [9] [10] [11] [12] [13] [14] Hearing ability relies on the rapid gating of the mechanoelectrical transduction (MET) channels believed to be located in the tip of the hair cell stereocilia (Figure 2A ). 15, 16 The genes encoding the MET channel have not yet been identified. Transmembrane channel 1 and 2 genes (TMC1 and 2) are 2 candidates encoding the MET channels in the stereocilia. 17, 18 Furthermore, the MET channels are believed to bind directly to the tip link between the adjacent cilia consisting of the cadherin 23 (CDH23) and protocadherin 15 (PCDH15). Movement of the stereocilia mechanically pulls the MET channels and potassium ion (K + ) included in the endolymph flow into the IHCs (Figure 3 ). 9, 11, 16 This potassium ion incorporation results in depolarization of the IHCs, and the subsequent opening of the voltage-dependent calcium channels. 9, 19 Calcium ions (Ca 2+ ) act as triggers for the exocytosis of vesicles, which contain the neurotransmitter glutamate. 11, 16, 19 The majority (95%) of the fibers of the auditory nerve, which conveys electric stimulation to the brain, arise from IHCs. At the bottom of the IHCs is another unique component known as the ribbon synapse. The ribbon synapse is a type of neuronal synapse consisting of thousands of vesicles. This multivesicular component acts as a large reservoir of the glutamate neurotransmitter. The broad dynamic range of IHC sound sensing is ensured by the rapid, multiple vesicular exocytosis of the ribbon synapse at a level corresponding to the loudness of the sound. 19, 20 Otoferlin (encoded by OTOF) is known to play an important role in this calciumdependent exocytosis process, with otof knockout mice displaying deafness due to the absence of exocytosis in IHCs. 21 With regard to gene expression, various genes linked to deafness are expressed in IHCs and in outer hair cells (OHCs; Figure 1 ). This reflects the unique and important characteristics of IHCs in the sound transduction mechanisms. To examine the gene expression linked to deafness in IHCs, we analyzed the gene ontology and searched a number of databases. As a result, gene expression in the IHCs and OHCs was characterized into 4 groups of genes.
The first group of genes is associated with vesicle transport, neuronal transmission, and calcium-binding functions. This group includes CABP2 (calcium-binding protein 2), membrane traffic protein OTOF (otoferlin), SLC17A8 (vesicular glutamate transporter 3), and TBC1D24 (TBC domain-containing RAB-specific GTPase-activating protein 24). Mutations in these genes are known to cause DFNB93, DFNB48, DFNB9, DFNA25, and DFNA65/ DFNB86. [22] [23] [24] [25] [26] The limited expression of these genes in the sensor cells and neurons reflects the importance of calcium ion (Ca 2+ ) and vesicle transport for effective neuronal transmission. TMPRSS3 (transmembrane protease serine 3) is a serine protease required for epithelial sodium channel (ENaC) maturation, and TMPRSS3 expression is also limited in IHCs, OHCs, and spiral ganglions. 27 The second group of genes consists of components of the stereocilia and includes ACTG1 (actin gamma 1), CDH23 (cadherin 23), CIB2 (calcium-and integrin-binding family member 2), ESPN (espin), MYO3A (myosin IIIa), MYO7A (unconventional myosin VIIa), MYO15A (unconventional myosin XV), PCDH15 (Protocadherin 15), PDZD7 (PDZ domain-containing 7), RDX (radixin), STRC (stereocilin), TMC1 (transmembrane channel-like protein 1), TPRN (taperin) TRIOBP (TRIO and F-actin-binding protein), USH1C (harmonin), USH2A (usherin), and WHRN (whirlin) (Figures 2A, 2B) . Mutations in these genes also cause hearing 
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Epidermal growth factor receptor kinase substrate 8 Required for postnatal maturation of hair bundles and also has potassium channel activity. GIPC3 is required for long-term survival of hair cells and spiral ganglion.
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GJB2
Gap junction protein, beta 2 DFNA3A/ Gap junction protein gated by voltage. GJB3 closes at low pH when exposed to long-chain alkanols.
GJB6
Gap junction protein, beta 6 DFNA3B/ Large, calcium-binding protein expressed in the ankle link of stereocilia. VLGR1 directly binds to PDZD7. VLGR1 also expressed in the synaptic region of hair cells.
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Lipoma HMGIC fusion partner-like 5 Tight junction protein that contributes to the structure and function of tricellular contacts between neighboring cells.
MIR96
Micro-RNA 96 Involved in the oxi-reduction of oxidized methionine residues. MSRB3 is required for the repair of oxidatively damaged proteins.
MYH9
Myosin, heavy chain 9, non-muscle is localized in the tip density region of stereocilia and acts in the maintenance of stereocilia morphology.
MYO6
Unconventional myosin VI Cytoskeletal protein that may be involved in anchoring actin to the plasma membrane of cochlea stereocilia. Endcodes the taparin protein, which is localized in the tapered region of each stereocilium. Taperin is required for the tapered structure of stereocilia.
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Gene ontology analyses were performed using PANTHER software as described previously. loss. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Most of the Usher syndrome causative genes are included in this group and are expressed in the stereocilia (Figures 2A, 2B ). LOXHD1 and GIPC3 are not components of the stereocilia; however, mutations in these genes in mice were shown to lead to degeneration of the stereocilia. [43] [44] [45] All of these genes are only expressed in the IHCs and OHCs. The third group comprises nuclear binding protein, transcription factor, receptor, and signaling molecule genes, including SIX1 (Sine oculis homeobox drosophila homolog 1), POU4F3 (POU domain class 4 transcription factor 3), EDN3 (endothelin 3), EDNRB (endothelin receptor type B), EPS8 (epidermal growth factor receptor kinase substrate 8), and GPSM2 (G-protein signaling modulator 2). These genes may have an important role in the transcription signaling pathway in IHC and OHC differentiation ( Figure 3A) . [46] [47] [48] [49] [50] [51] [52] The fourth group of genes comprises genes encoding tight junction proteins, including MARVELD2 (tricellulin), TJP2 (tight junction protein ZO 2), and CLDN14 (claudin 14). These genes are components of the tight junctions. MARVELD2 is expressed only in the IHCs and OHCs, while TJP2 is expressed in the IHCs, OHCs, pillar cells, and adjacent supporting cells, and CLDN14 is expressed in the IHCs, OHCs, supporting cells, and Reissner's membrane.
The tight junctions of these cells are believed to act as barriers that are required for normal hearing. Moreover, tricellulin proteins in the IHCs and OHCs form connections with adjacent cells and may prevent potassium ion (K + ) leakage from the apical side of hair cells. [53] [54] [55] 
Outer Hair Cells Are the Center for Cochlea Amplification
OHCs in the organ of Corti are organized into 3 lines of cells that act as amplifiers of auditory signals. Similar to IHCs, OHCs also have stereocilia at the top of the cells. The OHC stereocilia are attached to the tectorial membrane; however, IHC stereocilia do not come into contact with the tectorial membrane. OHCs are electromotile, acting as an amplifier of basilar membrane vibrations. When OHCs are depolarized by K + ions from the stereocilia, motor proteins (prestin) located on the surface of the OHCs are shortened. As a result of the prestin movement, OHCs shrink in synchronization with basilar membrane vibrations. 56, 57 As a result of this erector-evoked movement of the OHCs, basilar membrane movements are amplified, and the stereocilia of IHCs undergo more extensive swaying. This mechanism plays an important role in enhancing the dynamic range of sound sensors in the IHCs, particularly for low-intensity sounds. 56, 57 The movement of prestin itself does not require ATP as an energy source. Rather, changes in voltage capacity cause conformational changes in the prestin on the OHC surface membrane, thereby acting as the motor to drive these movements. OHCs are also controlled by efferent neurons, which act as a feedback system and modulate these movements. 58 Many genes are involved in the maintenance of this unique characteristic of OHCs (Figure 1 ), and mutations in these genes also cause hearing loss. The gene expression profiles of OHCs are quite similar to those of IHCs, and most genes are commonly expressed in both OHCs and IHCs; however, the expression of the mechanical amplification motor protein (prestin) gene SLC26A5 is restricted to OHCs. Three myosin motor proteins encoded by MYO3A, MYO7A, and MYO15A are expressed only in IHCs and OHCs. These genes may contribute to effective mechanical transduction and may also be involved in effective sound amplification by OHCs.
Pillar Cells Are Anchors for the Basilar Membrane and Hair Cells
Pillar cells act as the supporting cells located between IHCs and OHCs and are characterized by the presence of cross-linked actin filaments that ensure the necessary stiffness to support the hair cells on the basilar membrane and synchronize the vibration of the basilar membrane and hair cells. Pillar cells express actin gamma encoded by ACTG1 and tight junction proteins encoded by CLDN14 and TJP2. 54, 59, 60 The gene expression profiles of pillar cells are similar to those of hair and other supporting cells; ACTG1 expression is only observed in hair and pillar cells. 28, 52 In contrast, many types of myosin and various stereocillia components are not expressed in pillar cells. The gap junction proteins are commonly observed among the cochlea supporting and lateral wall cells, and those encoded by GJB2 and GJB6 are also observed in these cells. 61 
Inner Phalangeal Cells, Border Cells, and Deiters' Cells Are Neuroglial Cells in the Organ of Corti
Inner phalangeal cells, border cells, and Deiters' cells are all located adjacent to hair cells. Deiters' cells act as the supporting cells for OHCs and conform to the shape of the OHCs, while inner phalangeal cells and border cells act as the supporting cells for IHCs and conform to their shape. Furthermore, all of the aforementioned cells possess actin filaments and microtubules stretching from the basilar membrane to the reticular membrane in order to anchor the hair cells in the appropriate positions.
Another important role played by inner phalangeal and border cells is the glial cell-like uptake of the glutamate neurotransmitter, which is converted to glutamine. [62] [63] [64] After this conversion, glutamine is transported to the hair cells, converted back to glutamate, and stored in the synaptic ribbon vesicles. [62] [63] [64] The expression of tight junction proteins CLDN14 and TJP2 is expressions are only observed in hair, pillar, inner phalangeal cell, Border cell, and Deiters' cells. Methionine-R-sulfoxide reductase B3 (MSRB3) acts as an oxidoreductase, and its expression is only observed in hair, spiral ganglion, and inner phalangeal cell and Border and Deiters' cells. [65] [66] [67] [68] [69] [70] [71] [72] Mutations in MSRB3 cause DFNB74, [65] [66] [67] [68] [69] [70] [71] [72] revealing the importance of decreasing oxidative stress in the protection of hair and nerve cells. In contrast, many types of myosin and stereocillia components are not expressed in inner phalangeal, border, or Deiters' cells. However, gap junction proteins are commonly observed among the cochlea supporting and lateral wall cells, and those encoded by GJB2 and GJB6 are observed in this cell type. Mutations in gap junction genes are known to cause nonsyndromic hearing loss DFNA3A/ DFNB1A and DFNB1B. 66, 67 The Spiral Prominence Is the Center for Chloride, Bicarbonate, and Iodide Ion Transport Hensen's and Claudius' cells are located adjacent to Deiters' cells. External sulcus cells and the spiral prominence are connected to the organ of Corti and stria vascularis. Most of these cells produce pendrin, which is encoded by SLC26A4. Pendrin acts as a chloride (Cl − ), bicarbonate (HCO 3 − ), and iodide (I − ) ion transporter and is expressed in the cochlea, kidney, and thyroid gland. Mutations in SLC26A4 result in nonsyndromic hearing loss with an enlarged vestibular aqueduct (DFNB4) and Pendred syndrome (hearing loss and goiter are the main symptoms). [68] [69] [70] Among the supporting cells, the spiral prominence strongly expresses SLC26A4 and is believed to be responsible for maintaining Cl − and HCO 3 − ion concentrations.
The Stria Vascularis and Spiral Ligament Are Batteries for Mechanical Transduction
The scala media of the cochlea is filled with endolymph, which has a high positive potential (+80 mV) due to the high concentration of K + ions (150 mM). 10, 71, 72 The scala vestibuli and scala tympani are filled with perilymph, which has no potential (0 mV) and a low concentration of K + ions (5 mM). The endocochlear potential (EP) and high concentration of K + ions act as an energy source for efficient mechanoelectric transduction. This unique fluid is produced by the stria vascularis and spiral ligament. The stria vascularis is composed of 3 layers of cells (marginal, intermediate, and basal cells), with narrow intrastrial spaces (IS) between the marginal and intermediate cell layers. Basal and intermediate cells are connected to each other by gap junctions and the K + ions of the perilymph are transported into the basal cells by the Na + /K + ATPase and Na + /K + /2Cl − co-transporter (NKCC) located on the basolateral side of the basal cells ( Figure 2C ). On the apical surface of the intermediate cells, Kir4.1 encodes a potassium channel that transports K + ions to the IS. 10, 71, 72 Marginal cells have NKCC and Na + /K + ATPase at the basolateral surfaces and voltagegated K + channels (KQT-like subfamily and ISK-related subfamily members) at the apical membranes; the genes for these channels are KCNQ1 and KCNE1, respectively. 10, 72 As a result of nonequivalent expression patterns on the basolateral and apical sides of the intermediate and marginal cells, K + ions are efficiently pumped from the perilymph to the endolymph and Na + ions are returned to the perilymph 10,72 ( Figure 2C) . This system requires ATP as an energy source, and blood vessels located in the stria vascularis supply oxygen and nutrients for ATP synthesis. The stria vascularis expresses many unique genes. KCNQ1 and KCNE1 are genes for the K + channels expressed on the apical surface of the marginal cells of the stria vascularis. Mutations in these genes cause Jervell and Lange-Nielsen syndrome, which is characterized by congenital deafness, and long QT syndrome. [73] [74] [75] Paired box gene 3 (PAX3), SRY-Box 10 (SOX10), and Endothelin 3 (EDN3) are expressed in the stria vascularis. PAX3, SOX10, MITF, EDNRB, and EDN3 are reported to be causative genes of Waardenburg syndrome. [76] [77] [78] [79] PAX3 and SOX10 encode transcriptional activator proteins and directly bind to the promoter of the MITF, EDNRB, and RET genes ( Figure 3B ). 78 MITF codes for the protein that is presumed to be a transcriptional factor associated with melanocyte differentiation. 79 In the organ of Corti, melanocytes are observed only in the stria vascularis and may have an important role in oxidoreductase activity.
The Tectorial Membrane Is a Sound Signal Enhancer
The tectorial membrane is a component of the organ of Corti and is comprised of collagens and non-collagenous glycoproteins; the membrane covers both the IHCs and OHCs. The longest OHCs stereocilia are connected to the tectorial membrane, and amplification of basilar membrane movement by the OHCs causes the endolymph to flow between the organ of Corti and tectorial membrane. As a result of this endolymph flow, IHCs more efficiently transduce sound signals.
Gene mutations associated with the tectorial membrane also causes hearing loss. Collagen, encoded by COL2A1, COL9A1, COL9A3, and COL11A1, is a component of the tectorial membrane, and mutations in these genes appear to be related to nonsyndromic hearing loss or Stickler syndrome. [80] [81] [82] [83] [84] The collagen genes associated with hearing loss are not distributed in the IHCs, OHCs, or adjacent supporting cells, external sulcus cells, or the spiral prominence. [80] [81] [82] [83] [84] [85] [86] Further, no type IV collagen genes, including COL4A3, COL4A5, and COL4A6, are components of the tectorial membrane. Mutations in the type IV collagen genes cause Alport syndrome. This differential expression pattern among collagen genes might contribute to the differential roles of collagen in the hearing system. Inner ear-specific glycoproteins, coded by TECTA, OTOG, and OTOGL, are also expressed in the tectorial membrane. Mutations in TECTA cause DFNA8/12/DFNB21, those in OTOG cause nonsyndromic hearing loss, and those in OTOGL cause DFNB84. [87] [88] [89] Gene mutations in the tectorial membrane components can cause mild to moderate hearing loss (termed cochlear conductive hearing loss), and hearing aids are effective for such. This may indicate that gene mutations in the tectorial membrane components can cause a malformation of the membrane, which is required for enhancing sound signals.
Reissner's Membrane Separates the Perilymph and Endolymph
Reissner's membrane is a component of the cochlea, separating the scala vestibuli and the scala media. Reissner's membrane comprises 2 cell layers and tight junction proteins that prevent the leakage of the endolymph into the perilymph. CLDN14, which encodes tight junction proteins and CDH23 are expressed in Reissner's membrane. 55, 90 
Gene Expression Profiles of the Vestibular Endorgans
Our review also focused on the vestibular system. Most of the genes associated with hereditary hearing loss are also expressed in the vestibular endorgans. However, only a limited number of genes, namely, COCH and SLC26A4, have been reported to be associated with vestibular dysfunctions and/or vertigo, [91] [92] [93] [94] and the involvement of these genes remains unclear. In the vestibular system, mechanical transduction occurs by linear and rotatory acceleration. This mechanoelectric transduction is conducted by the hair cell stereocilia of the utricle and saccule together with the crista-ampullaris of the semicircular canals. Hair cells of the vestibular endorgans are slightly different from those of the organ of Corti. Vestibular stereocilia are linked to the kinocilium, and stereocilia movement toward the kinocilium depolarizes the hair cells.
Unlike the cochlea, only a limited number of reports are available for deafness-related causative genes expressed in the vestibular endorgans. A large proportion of the causative genes for deafness are also expressed in the vestibular endorgans, with the currently available information indicating that only 2 out of 72 genes (MITF and MYH9) are restricted to the cochlea. This may reflect differences between the cochlea and vestibular endorgans (Figure 4) .
The remaining genes are expressed in both the cochlea and vestibular endorgans; thus, it is difficult to explain the absence of vertigo in most patients. Possible explanations for this inconsistency are as follows: (1) other molecules compensate for the functional loss of sensory activity in the vestibular endorgans, (2) congenital vestibular dysfunction is compensated by visual and somatosensory input, and (3) the vestibular sensory system requires a lower degree of sensitivity than does the audio system. It is noteworthy that a missense mutation in CDH23 causes DFNB12, and vertigo is not associated with the mutation. Nonsense or frameshift mutations, which have more deleterious effects on protein function, cause Usher syndrome type 1D, which is characterized by retinitis pigmentosa and vertigo. Some of these inconsistencies can be explained by the third point; however, further studies are required to elucidate the effects of mutations linked to deafness on vestibular functions. 29, 95, 96 
Gene Expression Profiles of Genes Causing Deafness in Other Body Parts
Some mutations in the deafness causative genes only cause hearing loss (nonsyndromic hearing loss); however, others cause syndromic hearing loss with various associated symptoms. The presence of these associated symptoms may be related to the expression profiles of the genes correlated with deafness in other parts of human body. To elucidate the gene expression profiles of genes previously reported to cause deafness, we conducted the database search summarized in Table 4 . We also added information on the domain structure and protein interactions. Most of the genes known to cause deafness, including GJB2, CDH23, and TECTA, are expressed mainly in the cochlea; only a small percentage are expressed in other body parts. In contrast, most genes causing syndromic hearing loss, including COL4A3, COL4A4, COL4A5 (Alport syndrome); COL2A1, COL9A1, COL11A1, COL11A2 (Stickler syndrome); PAX3 (Waardenburg syndrome); and EYA1 (BOR syndrome), are expressed in other parts of the human body. These results can satisfactorily explain the presence of various symptoms in addition to hearing loss. However, many of the genes associated with nonsyndromic hearing loss are also expressed in other body parts. Further investigation is needed to elucidate the mechanisms underlying nonsyndromic hearing loss. One possible explanation of the aforementioned inconsistencies is the presence of alternative splicing variants as OTOF transcription variants NM_001100393 and NM_001144074 are expressed in the brain and kidney to some extent, while NM_004802 and NM_194248 are not observed in other body parts and are only expressed in the cochlea. 97 
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